CANY
VRNA

Caxton Associates (New York)’s Verona Pharma VRNA Stock Holding History

Caxton Associates (New York)’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		$1.37M Buy
+29,552
New +$1.37M 0.04% 162